5-Cyano-2-methylphenylboronic acid

5-Cyano-2-methylphenylboronic acid Suppliers list
Company Name: PharmaBlock Sciences (Nanjing),Inc.  
Tel: 025-86918202 4000255188
Email: sales@pharmablock.com
Company Name: Shanghai Hanhong Scientific Co.,Ltd.  
Tel: 021-54306202 13764082696
Email: info@hanhongsci.com
Company Name: Shanghai Cuisen Pharmaceutical Technology Co., Ltd.  
Tel: 13472757003
Email: yongnan.wang@cendrix.cn
Company Name: Shanghai Topbiochem Technology Co., Ltd  
Tel: 021-58170097
Email: info@topbiochem.com
Company Name: Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.  
Tel: 025-66113011 13913916777
Email: cfzhang@aikonchem.com

5-Cyano-2-methylphenylboronic acid manufacturers

5-Cyano-2-methylphenylboronic acid Basic information
Product Name:5-Cyano-2-methylphenylboronic acid
Synonyms:5-Cyano-2-methylphenylboronic acid;Boronicacid,B-(5-cyano-2-methylphenyl)-;(5-Cyano-2-methylphenyl)boronic acid 97%;(5-Cyano-2-methylphenyl)boronic acid(contains varying amounts of Anhydride)
CAS:867333-43-5
MF:C8H8BNO2
MW:160.97
EINECS:
Product Categories:
Mol File:867333-43-5.mol
5-Cyano-2-methylphenylboronic acid Structure
5-Cyano-2-methylphenylboronic acid Chemical Properties
Boiling point 373.4±52.0 °C(Predicted)
density 1.20±0.1 g/cm3(Predicted)
storage temp. Inert atmosphere,Room Temperature
pka7.25±0.58(Predicted)
AppearanceWhite to off-white Solid
Safety Information
HS Code 2931900090
MSDS Information
5-Cyano-2-methylphenylboronic acid Usage And Synthesis
Synthesis
Trimethyl borate

121-43-7

3-Bromo-4-methylbenzonitrile

42872-74-2

5-Cyano-2-methylphenylboronic acid

867333-43-5

Step 1: Synthesis of 5-cyano-2-methylphenylboronic acid First, 9.5 g (50 mmol) of 3-bromo-4-methylbenzonitrile was placed in a 500 mL three-necked flask and the atmosphere inside the flask was replaced with nitrogen. Then, 250 mL of tetrahydrofuran (THF) was added and the mixture was stirred at -78 °C for 30 min. Slowly 34 mL (55 mmol) of 1.63 M hexane solution of n-butyllithium (n-BuLi) was added dropwise to the above mixture and the reaction was maintained at -78 °C for 1.5 hours. Subsequently, 7.3 mL (65 mmol) of trimethyl borate was added to the reaction system, and the reaction solution was slowly warmed to room temperature and stirred for 20 hours. Upon completion of the reaction, 100 mL of 1 M hydrochloric acid was added to the system and stirred for 30 minutes. The reaction mixture was transferred to a partition funnel and the aqueous and organic layers were separated. The aqueous layer was extracted with ethyl acetate, the organic phase and extract were combined and washed with saturated sodium chloride solution. Anhydrous magnesium sulfate was added to the washed organic phase to dry. After drying, gravity filtration was performed and the filtrate was concentrated to obtain the crude product. The crude product was washed with toluene and hexane to give 4.3 g of white solid in 53% yield. The resulting white solid was confirmed to be 5-cyano-2-methylphenylboronic acid by nuclear magnetic resonance (NMR) spectral analysis. The synthesis scheme of step 1 is shown below (a-10).

References[1] Patent: WO2016/203350, 2016, A1. Location in patent: Paragraph 1195
[2] Journal of the American Chemical Society, 2002, vol. 124, # 31, p. 9014 - 9015
5-Cyano-2-methylphenylboronic acid Preparation Products And Raw materials
Raw materialsTrimethyl borate-->3-Bromo-4-methylbenzonitrile-->Tetrahydrofuran-->n-Butyllithium
Tag:5-Cyano-2-methylphenylboronic acid(867333-43-5) Related Product Information
2-hydrazino-5-methylpyrazine 5-Fluoro-2-hydroxymethylphenylboronic acid Boronic acid, (4-cyano-3-methoxyphenyl)- (9CI) 5-(hydroxymethyl)furan-2-ylboronic acid (4-Fluoro-2-(hydroxyMethyl)phenyl)boronic acid 5-Methoxy-2-methyl-benzoic acid 3-Chloro-4-(2'-fluorobenzyloxy)phenylbo& 3-Chloro-5-(trifluoromethyl)benzeneboronic acid 3,5-Difluoro-4-methoxy-phenylboronic acid 3-Trifluoromethyl-4-methoxy-phenylboronic acid 2-Methyl-5-(4-nitrophenyl)-1,3,4-oxadiazole 2-Fluoro-3-tolylboronic acid 5-iodo-2-MethylPhenol 3-Pyridinecarboxylic acid, 5-aMino-2-Methyl- 2-methyl-5-phenyl-1,3,4-oxadiazole 5-Bromo-2-methyl-4-pyrimidinecarboxylic acid 1H-Benzimidazol-5-ol,2-methyl-(9CI) Ethyl 2-methyl-5-pyrimidinecarboxylate